Copyright Reports & Markets. All rights reserved.

Global Cancer Drug Therapy Market Research Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Cancer Drug Therapy Industry
  • 1.7 COVID-19 Impact: Cancer Drug Therapy Market Trends

    • 2 Global Cancer Drug Therapy Quarterly Market Size Analysis

    • 2.1 Cancer Drug Therapy Business Impact Assessment - COVID-19
      • 2.1.1 Global Cancer Drug Therapy Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Cancer Drug Therapy Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Cancer Drug Therapy Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Cancer Drug Therapy Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Cancer Drug Therapy Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Cancer Drug Therapy Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Cancer Drug Therapy Market
    • 3.5 Key Manufacturers Cancer Drug Therapy Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Cancer Drug Therapy Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Targeted Therapy
      • 1.4.2 Chemotherapy
      • 1.4.3 Immunotherapy
    • 4.2 By Type, Global Cancer Drug Therapy Market Size, 2019-2021
      • 4.2.1 By Type, Global Cancer Drug Therapy Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Cancer Drug Therapy Price, 2020-2021

    5 Impact of Covid-19 on Cancer Drug Therapy Segments, By Application

    • 5.1 Overview
      • 5.5.1 Angiogenesis Inhibitors
      • 5.5.2 mTOR Inhibitors
      • 5.5.3 Monoclonal Antibodies
      • 5.5.4 Cytokine Immunotherapy (IL-2)
    • 5.2 By Application, Global Cancer Drug Therapy Market Size, 2019-2021
      • 5.2.1 By Application, Global Cancer Drug Therapy Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Cancer Drug Therapy Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Amgen / Allergan
      • 7.1.1 Amgen / Allergan Business Overview
      • 7.1.2 Amgen / Allergan Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.1.3 Amgen / Allergan Cancer Drug Therapy Product Introduction
      • 7.1.4 Amgen / Allergan Response to COVID-19 and Related Developments
    • 7.2 Argos Therapeutics
      • 7.2.1 Argos Therapeutics Business Overview
      • 7.2.2 Argos Therapeutics Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.2.3 Argos Therapeutics Cancer Drug Therapy Product Introduction
      • 7.2.4 Argos Therapeutics Response to COVID-19 and Related Developments
    • 7.3 AstraZeneca
      • 7.3.1 AstraZeneca Business Overview
      • 7.3.2 AstraZeneca Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.3.3 AstraZeneca Cancer Drug Therapy Product Introduction
      • 7.3.4 AstraZeneca Response to COVID-19 and Related Developments
    • 7.4 Aveo Pharmaceuticals
      • 7.4.1 Aveo Pharmaceuticals Business Overview
      • 7.4.2 Aveo Pharmaceuticals Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Product Introduction
      • 7.4.4 Aveo Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.5 Bayer
      • 7.5.1 Bayer Business Overview
      • 7.5.2 Bayer Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.5.3 Bayer Cancer Drug Therapy Product Introduction
      • 7.5.4 Bayer Response to COVID-19 and Related Developments
    • 7.6 Exelixis
      • 7.6.1 Exelixis Business Overview
      • 7.6.2 Exelixis Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.6.3 Exelixis Cancer Drug Therapy Product Introduction
      • 7.6.4 Exelixis Response to COVID-19 and Related Developments
    • 7.7 Incyte
      • 7.7.1 Incyte Business Overview
      • 7.7.2 Incyte Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.7.3 Incyte Cancer Drug Therapy Product Introduction
      • 7.7.4 Incyte Response to COVID-19 and Related Developments
    • 7.8 Merck
      • 7.8.1 Merck Business Overview
      • 7.8.2 Merck Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.8.3 Merck Cancer Drug Therapy Product Introduction
      • 7.8.4 Merck Response to COVID-19 and Related Developments
    • 7.9 Roche
      • 7.9.1 Roche Business Overview
      • 7.9.2 Roche Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.9.3 Roche Cancer Drug Therapy Product Introduction
      • 7.9.4 Roche Response to COVID-19 and Related Developments
    • 7.10 Bristol-Myers Squibb
      • 7.10.1 Bristol-Myers Squibb Business Overview
      • 7.10.2 Bristol-Myers Squibb Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.10.3 Bristol-Myers Squibb Cancer Drug Therapy Product Introduction
      • 7.10.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
    • 7.11 Eisai
      • 7.11.1 Eisai Business Overview
      • 7.11.2 Eisai Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.11.3 Eisai Cancer Drug Therapy Product Introduction
      • 7.11.4 Eisai Response to COVID-19 and Related Developments
    • 7.12 Exelixis
      • 7.12.1 Exelixis Business Overview
      • 7.12.2 Exelixis Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.12.3 Exelixis Cancer Drug Therapy Product Introduction
      • 7.12.4 Exelixis Response to COVID-19 and Related Developments
    • 7.13 Genentech (Roche)
      • 7.13.1 Genentech (Roche) Business Overview
      • 7.13.2 Genentech (Roche) Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.13.3 Genentech (Roche) Cancer Drug Therapy Product Introduction
      • 7.13.4 Genentech (Roche) Response to COVID-19 and Related Developments
    • 7.14 Novartis
      • 7.14.1 Novartis Business Overview
      • 7.14.2 Novartis Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.14.3 Novartis Cancer Drug Therapy Product Introduction
      • 7.14.4 Novartis Response to COVID-19 and Related Developments
    • 7.15 Pfizer
      • 7.15.1 Pfizer Business Overview
      • 7.15.2 Pfizer Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.15.3 Pfizer Cancer Drug Therapy Product Introduction
      • 7.15.4 Pfizer Response to COVID-19 and Related Developments
    • 7.16 Prometheus Labs
      • 7.16.1 Prometheus Labs Business Overview
      • 7.16.2 Prometheus Labs Cancer Drug Therapy Quarterly Production and Revenue, 2020
      • 7.16.3 Prometheus Labs Cancer Drug Therapy Product Introduction
      • 7.16.4 Prometheus Labs Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Cancer Drug Therapy Supply Chain Analysis
      • 8.1.1 Cancer Drug Therapy Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Cancer Drug Therapy Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Cancer Drug Therapy Distribution Channels
      • 8.2.2 Covid-19 Impact on Cancer Drug Therapy Distribution Channels
      • 8.2.3 Cancer Drug Therapy Distributors
    • 8.3 Cancer Drug Therapy Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Cancer Drug Therapy, including the following market information:
      Global Cancer Drug Therapy Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Cancer Drug Therapy Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Cancer Drug Therapy Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Cancer Drug Therapy Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck, Roche, Bristol-Myers Squibb, Eisai, Exelixis, Genentech (Roche), Novartis, Pfizer, Prometheus Labs, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Targeted Therapy
      Chemotherapy
      Immunotherapy

      Based on the Application:
      Angiogenesis Inhibitors
      mTOR Inhibitors
      Monoclonal Antibodies
      Cytokine Immunotherapy (IL-2)

      Buy now